“A randomized, single dose, two treatment, two period, crossover bioequivalence study of cefixime (as trihydrate) suspension in healthy participants comparing Acacime® suspension produced by ACAI / Iraq to Suprax® suspension produced by Hikma / Jordan” (2018) Al Mustansiriyah Journal of Pharmaceutical Sciences, 17(1), p. 7. doi:10.32947/ajps.v17i1.72.